Mounjaro Price Guide: Monthly Cost and Coverage Factors

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

You are reading this inside the PlexusDx Education Hub, where we unpack GLP-1 therapies, weight-management protocols, and the inherited biology that colors each of those choices. Browse the full Peptides & GLP-1 library.

“Cheap” is rarely the right frame for a branded GLP-1 medication, but “which levers actually move my cost” is. This guide organizes the Mounjaro pricing picture into the handful of factors that decide what you pay, so you can quickly identify which ones apply to you. Everything below reflects published information as of April 2026 and describes the landscape rather than promising any particular price.

Start from the list price

The published U.S. list price for Mounjaro is about $1,069 per month as of April 2026, per Eli Lilly. Think of it as the ceiling before anything is applied — insurance, rebates, manufacturer cards, and pharmacy pricing all work downward from there. Most insured patients never pay the full list figure.

Factor one: does your plan cover the indication

Commercial coverage turns on the FDA-approved indication written on the prescription and on the plan’s formulary and prior-authorization rules. Type 2 diabetes coverage is widespread. Chronic weight-management coverage is more variable, is often gated behind BMI-based prior authorization, and is sometimes excluded entirely. Medicare does not cover weight-management indications for weight alone as of April 2026, though some cardiovascular indications are covered.

Factor two: savings cards and coupons

Eli Lilly publishes a manufacturer savings card that can substantially cut monthly cost for eligible commercially-insured patients, subject to monthly and annual caps and typically excluding government coverage such as Medicare, Medicaid, and TRICARE. Independent platforms like GoodRx and SingleCare publish coupon prices that differ by pharmacy. Terms shift, so verify at fill.

Factor three: the compounding pathway

While the FDA listed semaglutide and tirzepatide in shortage, licensed 503A pharmacies compounded these molecules legally. The agency resolved the semaglutide shortage in late 2024 and the tirzepatide shortage in early 2025, narrowing but not eliminating legitimate compounding. Compounded products are not identical to the brand and are priced separately.

Putting the factors together

Covered indication plus an applied savings card can bring eligible patients’ monthly cost down to as little as $25, depending on plan terms and caps. Without covered indication, cash-pay lands nearer to list price minus any coupon. With no insurance at all, cost approaches list price, while compounded options through the PlexusDx Weight Management Protocols follow a separate pricing structure published on each product page.

The upstream factor most guides skip

Cost guides rarely mention the biology driving the decision. The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including variants in FTO, and MC4R that shape baseline appetite and energy balance. It does not predict response to any medication, but it grounds the conversation before you invest. PlexusDx offers semaglutide and tirzepatide, including Tirzepatide Injection, within those protocols.

A practical order of operations

If the goal is the lowest realistic cost, the sequence matters. Confirm coverage of the written indication first, because that single factor often swings the total more than anything else. Only then does it make sense to layer on card eligibility and compare independent coupons pharmacy by pharmacy.

What a guide cannot promise

No price guide can hand you a guaranteed number, because caps, formularies, and coupon prices all shift over time and differ by plan and location. What a guide can do is show you which lever applies to your situation so you spend your effort where it counts. Verifying the current figure at the point of fill, rather than trusting an older quote, keeps the plan grounded in what you will actually pay this month rather than what you paid last time. The same prescription can carry a very different price a season later, so treating any single figure as permanent is the most common way people misjudge the real cost.

Frequently Asked Questions

What is the single biggest driver of Mounjaro cost?

Coverage of the prescribed indication usually matters most. With a covered indication and an applied savings card, eligible patients may pay as little as $25 per month; without coverage, cost moves toward the roughly $1,069 list price as of April 2026, minus any coupon. Plan terms and caps decide the rest.

Can I lower the price without insurance?

Options exist but vary. Independent coupons from GoodRx or SingleCare may reduce cash-pay cost, and licensed 503A compounded semaglutide and tirzepatide are priced separately from the brand. Manufacturer savings cards generally require commercial insurance. Compare current terms at the pharmacy before you fill.

Why is weight-management coverage so inconsistent?

Plans set their own formularies and prior-authorization rules, and many gate weight-management indications behind BMI criteria or exclude them outright. Diabetes coverage is more uniform. Because rules differ plan to plan, the only reliable answer comes from checking your specific policy directly.

Does the genetic test lower my cost?

No. The Precision Peptide Genetic Test is not a discount program and never predicts drug response. It analyzes pathway-level variants such as FTO and MC4R to provide upstream metabolic context for your provider conversation — a test-before-you-invest step rather than a pricing tool.

Keep exploring the rest of the collection in the PlexusDx Education Hub.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.